JAZZ - Jazz Pharmaceuticals plc
183.63
-5.060 -2.756%
Share volume: 802,235
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$188.69
-5.06
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 02-26-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | 02-24-2026 | |
| Assets | |||||||||
| Total Assets | 11.327 B | 11.362 B | 12.256 B | 12.012 B | 11.535 B | 10.944 B | 11.356 B | 11.659 B | |
| Current Assets | 3.540 B | 3.682 B | 4.390 B | 4.629 B | 4.128 B | 3.350 B | 3.756 B | 4.166 B | |
| Inventories | 577.321 M | 542.555 M | 539.302 M | 480.445 M | 492.776 M | 504.989 M | 483.111 M | 416.962 M | |
| Other Current Assets | 314.535 M | 325.851 M | 354.215 M | 261.543 M | 259.823 M | 297.560 M | 315.441 M | 323.954 M | |
| Short Term Investments | 375.000 M | 625.000 M | 400.000 M | 580.000 M | 710.000 M | 480.000 M | 720.000 M | 1.050 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.443 B | 1.356 B | 2.218 B | 2.413 B | 1.862 B | 1.190 B | 1.326 B | 1.392 B | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 166.236 M | 169.281 M | 176.422 M | 173.413 M | 178.869 M | 184.975 M | 188.913 M | 199.857 M | |
| Other Assets | 7.621 B | 7.511 B | 7.689 B | 7.210 B | 7.228 B | 7.409 B | 7.412 B | 7.293 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 11.327 B | 11.362 B | 12.256 B | 12.012 B | 11.535 B | 10.944 B | 11.356 B | 11.659 B | |
| Total liabilities | 7.631 B | 7.599 B | 8.085 B | 7.919 B | 7.360 B | 7.238 B | 7.397 B | 7.341 B | |
| Total current liabilities | 1.562 B | 1.556 B | 1.030 B | 1.039 B | 1.223 B | 2.071 B | 2.274 B | 2.243 B | |
| Accounts Payable | 80.976 M | 97.096 M | 85.425 M | 77.869 M | 95.930 M | 89.366 M | 152.227 M | 122.061 M | |
| Other liabilities | 153.583 M | 167.033 M | 182.086 M | 125.552 M | 129.899 M | 148.838 M | 162.338 M | 175.411 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 5.105 B | 5.101 B | 6.081 B | 6.078 B | 5.336 B | 4.336 B | 4.332 B | 4.328 B | |
| Other liabilities | 153.583 M | 167.033 M | 182.086 M | 125.552 M | 129.899 M | 148.838 M | 162.338 M | 175.411 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.696 B | 3.763 B | 4.171 B | 4.094 B | 4.175 B | 3.706 B | 3.959 B | 4.319 B | |
| Common stock | 3.714 B | 3.779 B | 3.838 B | 3.914 B | 3.925 B | 4.000 B | 4.086 B | 4.240 B | |
| Retained earnings | 864.038 M | 871.178 M | 936.232 M | 1.127 B | 1.035 B | 191.313 M | 442.725 M | 646.176 M |